Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Radiosurgery × CNS × Clear all

Phase

Phase NA 32 Phase 2 32 Phase 1 25 Phase 3 24 Phase 1/2 15 Phase EARLY_PHASE1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 CNS 1

Conditions

Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Glioblastoma 1

Interventions

Saline Solution 5 Dexmedetomidine 5 Sodium Chloride 4 Levetiracetam 3 trametinib 2 perampanel 2 dabrafenib 2 Sugammadex 2 Sevoflurane 2 Propofol 2 Magnetic Resonance Spectroscopy 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Gentamicins 2 Fluorescein 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 pegvisomant 1 naxitamab 1 gadoterate meglumine 1 gadobenic acid 1 dexketoprofen trometamol 1 clevidipine 1 Vincristine 1 Valproic Acid 1 Trastuzumab 1 Tranexamic Acid 1 Tramadol 1 Thiotepa 1 Temozolomide 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡